These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9885801)

  • 1. Positron emission tomography in partial epilepsies: the clinical point of view.
    Koutroumanidis M; Binnie CD; Panayiotopoulos CP
    Nucl Med Commun; 1998 Dec; 19(12):1123-6. PubMed ID: 9885801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies?
    Goethals I; Van de Wiele C; Boon P; Dierckx R
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):325-8. PubMed ID: 12552355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET studies in epilepsy.
    Decoo D; Destée A
    Acta Neurol Belg; 1997 Sep; 97(3):196-9. PubMed ID: 9345593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients.
    Ryvlin P; Bouvard S; Le Bars D; De Lamérie G; Grégoire MC; Kahane P; Froment JC; Mauguière F
    Brain; 1998 Nov; 121 ( Pt 11)():2067-81. PubMed ID: 9827767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography in presurgical localization of epileptic foci.
    Csaba J
    Ideggyogy Sz; 2003 Jul; 56(7-8):249-54. PubMed ID: 12971120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional neuroimaging with positron emission tomography.
    Henry TR
    Epilepsia; 1996 Dec; 37(12):1141-54. PubMed ID: 8956845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of positron emission tomography with [18F]fluorodeoxyglucose in the evaluation of the epilepsies.
    Henry TR; Votaw JR
    Neuroimaging Clin N Am; 2004 Aug; 14(3):517-35, ix. PubMed ID: 15324862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET tracer technology for monitoring focal epilepsies.
    Koepp MJ
    Expert Rev Med Devices; 2007 Mar; 4(2):191-200. PubMed ID: 17359224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy.
    Henry TR; Engel J; Mazziotta JC
    J Nucl Med; 1993 Nov; 34(11):1892-8. PubMed ID: 8229230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benzodiazepine receptor imaging with positron emission tomography and single photon emission tomography].
    Bartenstein P; Koepp M
    Nervenarzt; 1995 Jun; 66(6):412-21. PubMed ID: 7637827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread functional deficits in perception-related networks demonstrated by PET in a case with simple visual seizures.
    Mielke R; Weber-Luxenburger G; Kessler J; Szelies B; Heiss WD
    Epilepsia; 1997 Mar; 38(3):370-3. PubMed ID: 9070601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain molecular imaging in pharmacoresistant focal epilepsy: Current practice and perspectives.
    Verger A; Lagarde S; Maillard L; Bartolomei F; Guedj E
    Rev Neurol (Paris); 2018; 174(1-2):16-27. PubMed ID: 28595975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional imaging (PET and SPECT) in epilepsy].
    Borbély K
    Orv Hetil; 2001 Nov; 142(44):2405-14. PubMed ID: 11766233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
    Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
    Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic changes of subcortical structures in intractable focal epilepsy.
    Benedek K; Juhász C; Muzik O; Chugani DC; Chugani HT
    Epilepsia; 2004 Sep; 45(9):1100-5. PubMed ID: 15329075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional neuroimaging in adults].
    Ryvlin P; Mauguière F
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S117-30. PubMed ID: 15331957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy.
    Juhász C; Chugani DC; Muzik O; Watson C; Shah J; Shah A; Chugani HT
    Neurology; 2000 Sep; 55(6):825-35. PubMed ID: 10994004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study.
    Savic I; Svanborg E; Thorell JO
    Epilepsia; 1996 Mar; 37(3):236-44. PubMed ID: 8598181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interictal cerebral metabolism in partial epilepsies of neocortical origin.
    Henry TR; Sutherling WW; Engel J; Risinger MW; Levesque MF; Mazziotta JC; Phelps ME
    Epilepsy Res; 1991; 10(2-3):174-82. PubMed ID: 1817957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.